Inobrodib
Study to Evaluate CCS1477 (inobrodib) in Haematological Malignancies
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1/2
- Enrollment
- 250 patients (estimated)
- Sponsors
- CellCentric Ltd.
- Trial Type
- Treatment
- Last Update
- 3 months ago
- SparkCures ID
- 1718
- NCT Identifier
- NCT04068597
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.